Bicara Therapeutics Inc. – Filings and Transcripts

NASDAQ: BCAX
Share price (6/29/26): $29.34
Market cap (6/29/26): $1.928 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Bowden Christopher

Mazumdar-Shaw Kiran

Robertson Scott M.

News Filter

Shareholder Vote Results

Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC

Reports First Quarter 2026 Financial Results and Provides Business Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Material Definitive Agreement, Earnings Release or Operating Update, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

SEC STAFF LETTER